Pharmacotherapy for the Treatment of Cannabis Use Disorder
Authors: Devan Kansagara, Karli K. Kondo, Benjamin J. Morasco, Shannon M. Nugent, Chelsea K. Ayers
Journal: Annals of Internal Medicine (2020)

Letters4 August 2020Pharmacotherapy for the Treatment of Cannabis Use DisorderDevan Kansagara, MD, MCR, Karli K. Kondo, PhD, Benjamin J. Morasco, PhD, Shannon M. Nugent, PhD, and Chelsea K. Ayers, MPHDevan Kansagara, MD, MCRVA Portland Health Care System and Oregon Health & Science University, Portland, Oregon (D.K., K.K.K., B.J.M., S.M.N.)Search for more papers by this author, Karli K. Kondo, PhDVA Portland Health Care System and Oregon Health & Science University, Portland, Oregon (D.K., K.K.K., B.J.M., S.M.N.)Search for more papers by this author, Benjamin J. Morasco, PhDVA Portland Health Care System and Oregon Health & Science University, Portland, Oregon (D.K., K.K.K., B.J.M., S.M.N.)Search for more papers by this author, Shannon M. Nugent, PhDVA Portland Health Care System and Oregon Health & Science University, Portland, Oregon (D.K., K.K.K., B.J.M., S.M.N.)Search for more papers by this author, and Chelsea K. Ayers, MPHVA Portland Health Care System, Portland, Oregon (C.K.A.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L20-0691 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Drs. Brezing and Levin outline several factors that contribute to uncertainty of this body of evidence. They also underscore the need for further research in several specific areas related to treatment of CUD. We largely agree with their observations and the call for more research. We disagree with their concern that the findings reported in our systematic review might stifle future research. Indeed, a key purpose of a systematic review in a field with a nascent evidence base is to provide a foundation for future research by outlining precisely what is and is not known. It is important ...Reference1. Berkman N, Lohr K, Ansari M, et al. Grading the Strength of a Body of Evidence When Assessing Health Care Interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality: An Update. Agency for Healthcare Research and Quality; 2013. Google Scholar Author, Article, and Disclosure InformationAffiliations: VA Portland Health Care System and Oregon Health & Science University, Portland, Oregon (D.K., K.K.K., B.J.M., S.M.N.)VA Portland Health Care System, Portland, Oregon (C.K.A.)Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-1105. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoPharmacotherapy for the Treatment of Cannabis Use Disorder Karli K. Kondo , Benjamin J. Morasco , Shannon M. Nugent , Chelsea K. Ayers , Maya E. O'Neil , Michele Freeman , and Devan Kansagara Pharmacotherapy for the Treatment of Cannabis Use Disorder Christina A. Brezing and Frances R. Levin Metrics 4 August 2020Volume 173, Issue 3Page: 248-249KeywordsAnxietyCannabinoidsCannabis useConflicts of interestDisclosureDrug therapyDrugsForecastingPsychiatry and mental healthSystematic reviews ePublished: 4 August 2020 Issue Published: 4 August 2020 PDF downloadLoading ...